Arkolith/Insider Trading/AADI/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Mar 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Sell(S)6K$2.35$13K33K
Mar 1, 2025Option exercise(M)16K——39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2025Option exercise(M)16K—$049K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006316) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML